Patents Assigned to EndoBiologics, Incorporated
  • Anti-sepsis conjugate vaccine
    Patent number: 8337863
    Abstract: The present invention provides an immunogenic conjugate comprising biologically deacylated gram-negative bacterial moieties linked to D. discoideum proteinase 1, as well as novel subunits thereof, and methods of making and using the conjugates in vaccines to treat sepsis and other infectious complications.
    Type: Grant
    Filed: February 6, 2012
    Date of Patent: December 25, 2012
    Assignee: EndoBiologics, Incorporated
    Inventors: Gary L. Gustafson, Dan C. DeBorde
  • ANTI-SEPSIS CONJUGATE VACCINE
    Publication number: 20120301500
    Abstract: The present invention provides an immunogenic conjugate comprising biologically deacylated gram-negative bacterial moieties linked to D. discoideum proteinase 1, as well as novel subunits thereof, and methods of making and using the conjugates in vaccines to treat sepsis and other infectious complications.
    Type: Application
    Filed: February 6, 2012
    Publication date: November 29, 2012
    Applicant: EndoBiologics, Incorporated
    Inventors: Gary L. Gustafson, Dan C. DeBorde
  • Anti-sepsis conjugate vaccine
    Patent number: 8128942
    Abstract: The present invention provides an immunogenic conjugate comprising biologically deacylated gram-negative bacterial moieties linked to D. discoideum proteinase 1, as well as novel subunits thereof, and methods of making and using the conjugates in vaccines to treat sepsis and other infectious complications.
    Type: Grant
    Filed: May 21, 2010
    Date of Patent: March 6, 2012
    Assignee: EndoBiologics, Incorporated
    Inventors: Gary L. Gustafson, Dan C. DeBorde
  • ANTI-SEPSIS CONJUGATE VACCINE
    Publication number: 20110027307
    Abstract: The present invention provides an immunogenic conjugate comprising biologically deacylated gram-negative bacterial moieties linked to D. discoideum proteinase 1, as well as novel subunits thereof, and methods of making and using the conjugates in vaccines to treat sepsis and other infectious complications.
    Type: Application
    Filed: May 21, 2010
    Publication date: February 3, 2011
    Applicant: EndoBiologics, Incorporated
    Inventors: Gary L. Gustafson, Dan C. DeBorde
  • Anti-sepsis conjugate vaccine
    Patent number: 7749511
    Abstract: The present invention provides an immunogenic conjugate comprising biologically deacylated gram-negative bacterial moieties linked to D. discoideum proteinase 1, as well as novel subunits thereof, and methods of making and using the conjugates in vaccines to treat sepsis and other infectious complications.
    Type: Grant
    Filed: November 15, 2005
    Date of Patent: July 6, 2010
    Assignee: EndoBiologics, Incorporated
    Inventors: Gary L. Gustafson, Dan C. DeBorde
  • Anti-sepsis conjugate vaccine
    Patent number: 7014857
    Abstract: The present invention provides an immunogenic conjugate comprising biologically deacylated gram-negative bacterial moieties linked to D. discoideum proteinase 1, as well as novel subunits thereof, and methods of making and using the conjugates in vaccines to treat sepsis and other infectious complications.
    Type: Grant
    Filed: October 15, 2002
    Date of Patent: March 21, 2006
    Assignee: EndoBiologics, Incorporated
    Inventors: Gary L. Gustafson, Dan C. DeBorde